Although researchers have made powerful new targeted treatment options available to oncologists who treat breast cancer patients, options such as pertuzumab are associated with high costs which raises questions about access as payers assess the value of treatment.
Although researchers have made powerful new targeted treatment options available to oncologists who treat breast cancer patients, options such as pertuzumab are associated with high costs which raises questions about access as payers assess the value of treatment. Pertuzumab, also known as Genentech’s Perjeta, is a recombinant humanized monoclonal antibody that is approved for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer.
According to the American Journal of Managed Care, in one clinical trial, women treated with combination therapy with pertuzumab experienced significant improvements in progression-free survival, or six months greater on average, compared to women who received combination treatment with a placebo. These and other key issues surrounding proper utilization and reimbursement were the focus of an expert panel discussion that the American Journal of Managed Care convened.
Read the full story here: http://bit.ly/16bHQL5
Source: PharmaLive
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen